.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Merck
Queensland Health
McKinsey
Farmers Insurance
Chinese Patent Office
Teva
US Army
Fish and Richardson

Generated: November 25, 2017

DrugPatentWatch Database Preview

CYTOXAN Drug Profile

« Back to Dashboard

Which patents cover Cytoxan, and when can generic versions of Cytoxan launch?

Cytoxan is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in CYTOXAN is cyclophosphamide. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
CYTOXAN
cyclophosphamide
TABLET;ORAL012141-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-005Aug 30, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN
cyclophosphamide
INJECTABLE;INJECTION012142-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-009Dec 10, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN
cyclophosphamide
TABLET;ORAL012141-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN
cyclophosphamide
INJECTABLE;INJECTION012142-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-010Sep 24, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-004Aug 30, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-008Jan 4, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Boehringer Ingelheim
Healthtrust
Medtronic
Chubb
Deloitte
Colorcon
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot